ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway

CAS OpenIR > 膜生物学国家重点实验室

	ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway
发表期刊	Cancer Research
	2008
卷号	68 期号:23 页码:9854-9864
	Hamai A; Meslin F; Benlalam H; Jalil A; Mehrpour M; Faure F; Lecluse Y; Vielh P; Avril MF; Robert C; Chouaib S
文献类型	期刊论文
条目标识符	http://ir.ioz.ac.cn/handle/000000/10471
专题	膜生物学国家重点实验室
推荐引用方式 GB/T 7714	Hamai A,Meslin F,Benlalam H,et al. ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway[J]. Cancer Research,2008,68(23):9854-9864.
APA	Hamai A.,Meslin F.,Benlalam H.,Jalil A.,Mehrpour M.,...&Chouaib S.(2008).ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway.Cancer Research,68(23),9854-9864.
MLA	Hamai A,et al."ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway".Cancer Research 68.23(2008):9854-9864.